OH2 injection for advanced solid tumors
Treatments studied
Part of Cancer clinical trials.
This trial tests an investigational injection (OH2) that goes directly into tumors. It may help shrink tumors and control cancer in people with certain advanced solid tumors who have run out of other options.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older
- You have a solid tumor (like melanoma, pancreatic, breast, or a liver metastasis from colon cancer) that can't be removed with surgery or has spread
- You have at least one tumor that can be safely injected with a needle
- You've tried standard treatments and they didn't work or you can't have them
- You have a life expectancy of at least 12 weeks and feel well enough (able to do daily activities)
- You are not pregnant and agree to use birth control, and men agree not to donate sperm
- You don't have serious heart disease, bleeding problems, or active infections like HIV or hepatitis
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of two injections, OH2 and BS006, for people with advanced solid tumors that have not responded to standard treatments. The injections are given directly into the tumor, aiming to shrink or control the cancer.
This early-stage study tests a virus therapy designed to attack solid tumors that cannot be removed by surgery or have returned/spread. It may help shrink tumors and control cancer in people whose standard treatments are no longer working.
This trial tests an experimental cell therapy for people with advanced solid tumors that have not responded to standard treatments. The therapy uses immune cells from your own tumor, grown in the lab and given back to you, potentially to help your body fight the cancer.
This study tests an experimental drug called SHR-4595 given as a shot (injection) to people with advanced solid tumors. The goal is to see if it is safe and how the body handles it, which might help shrink tumors or slow their growth.
This trial tests an experimental cell therapy (HS-IT101) for people with advanced solid tumors that have not responded to standard treatments. It uses immune cells from your own tumor to fight cancer, and researchers want to see if it is safe and effective.
This Phase 3 study tests OH2 injection in people with stage III or IV melanoma that has come back or spread after at least two prior treatment types. If you qualify, you may receive OH2 injection to help shrink tumors or slow disease progression.
Hear when a new Solid Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.